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538, UK-504, France-483), under 122 cardiologists, mean age 62
(SD 12), mean weight 80 kg (SD 15), 22% female were recruited
with co-morbidities of hypertension-53%, dyslipidemia-52%,
diabetes-20% and prior MI-23%. Index diagnosis was: non
ST-elevation ACS-62% and ST-elevation MI (STEMI)-38%.
Admission and discharge use of medications were: aspirin-36 &
95%, clopidogrel-21 & 94%, statins-37 & 84%, beta-
blockers-30 & 76% and ACE inhibitors/ARBs-34 & 67%. 2349
stents were used (DES-52%; France-33%, Spain-64%, UK-55%)
with 58% of patients receiving only one. A total of 51% of
patients were transferred at least once between study and another
hospital, France-54%, Spain-46%, UK-54%. Admission to PCI
at study hospital was: median 2 days (IQR 1–5 days) for non-ST
ACS patients, (65% 3 days or less; France-87%, Spain-72%,
UK-38%); and median 0 days (IQR 0–2 days) for STEMI
patients, (73% 1 day or less; France-82%, Spain-74%,
UK-58%). Total stay was median 6 days (IQR 4–9) for both
cohorts. QoL at hospital discharge using EQ-5D health state
index was: median 0.85 (IQR 0.71–1.00) with 1 representing
perfect health, (France-0.85 (0.73–1.00), Spain-0.85 (0.73–
1.00), UK-0.81 (0.68–1.00)). CONCLUSION: These data indi-
cate geographic and case mix variation in management of ACS
patients, including use of DES, but with uniform early QoL
ﬁndings. Use of pharmacotherapies is high. Long term QoL will
assess the impact of variations, but these early ﬁndings are useful
benchmarks to guide service provision, focus treatment guide-
lines and validate clinical trials.
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OBJECTIVE: To assess trends in utilization of stroke-related
outpatient physician services by physician specialty over the past
6 years. METHODS: This study was a retrospective analysis of
the National Ambulatory Medical Care Survey (NAMCS) from
2000–2005. Ischemic stroke related visits in persons aged 45
years were identiﬁed using diagnosis codes (ICD9CM) 433.1x,
434.xx, and 436.xx. Visits per/1000 persons were calculated
using United States population estimates. With logistic regres-
sion, we adjusted associations between stroke-related visits and
physician type (Neurology, Primary Care, and Cardiovascular
Medicine), for age, race, and region (Northeast, Midwest, West,
and South), sex, diabetes, hypertension, insurance type, and
survey year. RESULTS: From 2000 to 2005, stroke related out-
patient physician ofﬁce visits ambulatory care visits increased
signiﬁcantly from 4.7/1000 persons to 6.3/1000 (P
Trend =< 0.0001) persons, a 131% increase. During the study
period, the proportion of ambulatory stroke-related visits that
were to a neurologist increased signiﬁcantly from 15.5% in 2000
to 26.3% in 2005 (P Trend =< 0.0001). However, during the
same period, visits to primary care (2000: 74.4% vs. 2005:
67.8%), and cardiovascular medicine (2000: 10.0% vs. 2005:
5.9%) decreased. After adjustment, greater odds of stroke-
related visits to neurologist (OR = 10.6 95% CI: 7.9–14.1)
whereas no signiﬁcant differences were observed for cardiovas-
cular medicine (OR = 1.5 95% CI: 0.9–2.2) (Reference Category:
Primary Care). CONCLUSION: From 2000 to 2005, stroke-
related ambulatory physician visits increased signiﬁcantly overall
but particularly to neurologists. Secondary stroke prevention,
historically performed by primary care physicians in the US, may
be increasingly performed by neurologists. Given predictions for
large rises in stroke prevalence due to the aging population and
improved stroke survival, US demand for neurologists may be
insufﬁcient.
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OBJECTIVE: Disease state management (DSM) programs are
recommended for patients with conditions such as diabetes,
hypertension, and hyperlipidemia. However, the level of adop-
tion of these programs is not known. The objective of this
study is to determine the level of utilization of DSM programs
in the United States. METHODS: Data from the National
Ambulatory Medical Care Survey (NAMCS), which includes a
nationally representative sample of outpatient physician ofﬁce
visits, was used to meet the study objectives. In year 2005,
NAMCS included an additional item regarding enrollment in
DSM programs. Patients with diabetes, hypertension, or hyper-
lipidemia were identiﬁed and estimates for enrollment in DSM
programs were computed. Logistic regression analysis was used
to identify predictors of enrollment in such programs. Sample
weights and the complex sampling design of the NAMCS were
accounted in all the analyses. RESULTS: The ﬁnal study sample
included 3,884 patient visits. Patients with diabetes had the
highest rate of enrollment (24.6%), followed by patients with
hyperlipidemia (20.4%) and hypertension (19.5%). Insurance
status was an important predictor of enrollment status with
patients enrolled in Medicare [Odds Ratio (OR) = 1.68;
p = 0.021] and Medicaid (OR = 2.13; p = 0.008) signiﬁcantly
more likely to be enrolled in a DSM program as compared to
those without insurance. Patients of Hispanic ethnicity were
67% less likely to be enrolled in a DSM program (OR = 0.33;
p < 0.001). The only co-morbid condition that was a signiﬁcant
predictor of enrollment status was depression. Patients with
co-morbid depression were 1.87 times more likely to be
enrolled as compared to those without depression (OR = 1.87;
p = 0.004). CONCLUSION: Although the beneﬁts of DSM
programs have been documented, their adoption rate remains
extremely low. This study indicates that Hispanic ethnicity,
insurance status and co-morbid depression were predictors of
enrollment status. Additional studies are needed to identify
other predictors and to tailor interventions to increase the
adoption of such programs.
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OBJECTIVE: The primary aim was to determine the impact
on INR control resulting from the integration of information
on patient health literacy and numeracy, health knowledge and
health beliefs regarding warfarin therapy into the clinical infor-
mation provided to the pharmacist. METHODS: A single-
blinded randomized controlled study was conducted to test the
hypothesis that including information on patient’s health lit-
eracy, numeracy, and anticoagulation knowledge and beliefs
improves patient INR control. Patients were recruited from
anticoagulation management services at the University of Mary-
land Medical Center and the Baltimore VA Medical Center.
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